IAS 2015: Altered Cholesterol Metabolism May Protect Immune Cells of Non-Progressors
- Details
- Category: Search for a Cure
- Published on Tuesday, 11 August 2015 00:00
- Written by Liz Highleyman
Enhanced cholesterol metabolism in certain immune cells may help explain why some people with HIV can naturally control the virus with little or no disease progression, according to research presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention and at the preceding IAS Towards an HIV Cure Symposium last month in Vancouver. The findings suggest that regulating cellular cholesterol metabolism may offer a new approach to controlling HIV and potentially achieving a functional cure, or long-term remission.
IAS 2015: International AIDS Society Conference Starts this Weekend in Vancouver
- Details
- Category: HIV Treatment
- Published on Wednesday, 15 July 2015 00:00
- Written by HIVandHepatitis.com
The 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) starts this Sunday and runs July 19-22 in Vancouver. HIV prevention -- including treatment-as-prevention and pre-exposure prophylaxis (PrEP) -- will be a major focus of the meeting. Other topics will include antiretroviral drugs in development, expanding access to treatment and retention in care, and HIV/hepatitis coinfection. HIVandHepatitis.com will be on site covering the latest news.
Do Sex and HIV/HCV Coinfection Affect Response to Antiretroviral Treatment?
- Details
- Category: HIV Disease Progression
- Published on Wednesday, 27 May 2015 00:00
- Written by Liz Highleyman
HIV-positive men and women coinfected with hepatitis C virus (HCV) showed impaired CD4 T-cell restoration after starting antiretroviral therapy (ART) and had a 40% greater risk of death than people with HIV alone, though they were equally likely to achieve HIV viral suppression, according to study findings published in the May 18 advance edition of AIDS Patient Care and STDs.
Coverage of the 2015 International AIDS Society Conference
- Details
- Category: HIV Treatment
- Published on Monday, 06 July 2015 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), July 19-22, in Vancouver, Canada.
Conference highlights include HIV treatment as prevention, pre-exposure prophylaxis (PrEP), new antiretroviral therapies, HIV cure research, hepatitis C and HIV/HCV coinfection, and global scale-up of prevention and treatment.
7/22/15
BHIVA 2015: People Who Don't Reveal HIV Status Have as Good Health Outcomes as Those Who Do
- Details
- Category: HIV Disease Progression
- Published on Wednesday, 06 May 2015 00:00
- Written by Roger Pebody
A large survey of people attending HIV clinics in the UK has found that individuals who chose not to disclose their HIV status to other people were no more likely to suffer from depression or anxiety, to have difficulty adhering to antiretroviral therapy (AR), or to have worse HIV outcomes, according to research presented at the British HIV Association (BHIVA) annual meeting last month in Brighton.
More Articles...
- CROI 2015: Inflammation and Gut Damage Persist in People with HIV Despite Early ART
- Researchers May Have Caught HIV Becoming More Virulent in Cuba
- Elite Controllers Have Higher Hospitalization Rate, HIV May Hide in B-Cells
- Smoking Doubles Risk of Death for People with HIV Taking Antiretroviral Therapy